Análisis opcionales del producto
Con tu permiso, usamos análisis limitados y respetuosos con la privacidad para entender qué recorridos de investigación funcionan. No usamos rastreadores publicitarios ni grabación de sesiones. Puedes cambiar esta opción en Preferencias. Lee la Política de privacidad.
Linde plc's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $220.2B | |
|---|---|---|
| Revenue (ttm) | 35.4B | |
| Net income (ttm) | 7.2B | |
| EPS (ttm) | $15.5 | |
| Shares out | 461M | |
| P/E (trailing) | 32.8x | |
| P/E (forward) | 24.5x | |
| Dividend | $6.40 (1.26%) | |
| Volume | 1,632,304 | |
| Beta | 0.71 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $30.79B | $33.36B | $32.85B | $33.01B | $33.99B | +2.5% |
| Gross profit | $8.62B | $9.71B | $11.55B | $12.08B | $14.73B | +14.3% |
| Operating income | $4.98B | $5.37B | $8.02B | $8.64B | $8.92B | +15.7% |
| Net income | $3.83B | $4.15B | $6.20B | $6.57B | $6.90B | +15.9% |
| EPS (diluted) | $7.33 | $8.23 | $12.59 | $13.62 | $14.61 | +18.8% |
| EBITDA | $9.89B | $9.94B | $12.29B | $12.92B | $12.95B | +7.0% |
| R&D | $143.0M | $143.0M | $146.0M | $150.0M | $147.0M | +0.7% |
| SG&A | $3.19B | $3.11B | $3.30B | $3.34B | $3.43B | +1.9% |
Recent company headlines from major financial publishers.
The base path supports $266.68, but the shares remain rated Sell because the earnings path does not close the gap to $468.38 (as of 2026-09-08).
This case depends on the stated regional growth and cash-after-investment conditions. It is disconfirmed if recurring capex or valuation normalization overwhelms the earnings path.
| Ke ↓ / g → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.1% | $295 | $303 | $314 | $327 | $346 |
| 7.1% | $273 | $278 | $285 | $292 | $302 |
| 8.1% | $256 | $260 | $267 | $269 | $275 |
| 9.1% | $242 | $245 | $248 | $251 | $255 |
| 10.1% | $231 | $232 | $235 | $237 | $240 |
Upcoming earnings date and setup when available.
La calificación que llevaba la edición de análisis publicada cada mes. Una calificación compara el precio en la fecha del análisis con el valor razonable; no es un registro de si la valoración acertó.
| Año | ene | feb | mar | abr | may | jun | jul | ago | sept | oct | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |